Singapore: Takeda, AstraZeneca, Mitsubishi Tanabe and Eisai submitted a joint application to Japan's Ministry of Health...
Singapore: Japanese company, Takeda Pharmaceutical is looking to acquire Inviragen for an upfront payment of $35 million...
Singapore: Though its surface has been turned to carbon, the bunny-like features can still be easily observed with a mic...
Singapore: Japanese companies Dainippon Sumitomo Pharma and Takeda Pharmaceutical have obtained approval for marketing a...
Singapore: Medgenics received a Notice of Allowance from the Japanese Patent and Trademark Office for key claims protec...
Singapore: Pfizer Japan and Takeda Pharmaceutical have launched Xeljanz (tofacitinib citrate) in Japan. The medicine was...
Singapore: Japanese companies are keen to collaborate with pharmaceutical companies in India. A delegation of pharmaceut...
Singapore: Japan's Astellas Pharma has collaborated with US-based Ambrx for the discovery and development of novel antib...
Singapore: Japan-headquartered Eisai and its diagnostics business subsidiary Eidia have decided to dissolve and absorb t...
Singapore: Shimadzu UK has launched a high-end liquid chromatography mass spectrometer, the LCMS-8080, which delivers be...
Singapore: Takeda Pharmaceutical submitted a marketing authorization application (MAA) to the European Medicines Agency ...
Singapore: St Jude Medical, a global medical device company, has received approval from the Japanese Ministry of Health,...
In South Korea, two research teams led by Prof. Park Se-pill at Jeju National University Stem Cell Research Center and M...
Singapore: Exlites Holdings from the US has entered into an agreement with a company that will source new cutting edge m...
Singapore: New Zealand-based dairy biotechnology company, Quantec, announced that it has signed a distribution and suppl...
Singapore: Japan-based Otsuka Pharmaceutical and H Lundbeck have received US FDA approval for Abilify Maintena (aripipra...
Singapore: The US Food and Drug Administration (FDA) has issued guidance to the Active Pharmaceutical ingredient industr...
Singapore: Dezima Pharma, a biotechnology company developing innovative drugs in the field of dyslipidemia, has in-licen...
